Articles

GSK’s Alexvy vaccine is the first to receive FDA approval for respiratory syncytial virus.

FDA Approves First RSV Vaccine

Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.

Baxter Divests BioPharma Solutions Department in $4.25 Billion Deal

Boehringer Ingelheim will use Ginkgo’s metagenomic sequence database to identify potential lead molecules for diseases with high unmet patient needs.

Ginkgo Bioworks and Boehringer Ingelheim Sign $405 Million Drug Discovery Deal

According to a press release, SGS has doubled its capacity for nitrosamine testing for North American customers.

SGS Expands Nitrosamine Testing Capacity

The new portfolio from the acquisition will include contract research organization solutions, contract development and manufacturing organization solutions, and KSM/API solutions.

PI Healthsciences Acquires Archimica S.p.A from Livia Group

The new agreement is based off the Master Services Agreement that both companies entered in 2021 for the development, manufacture, and supply of rhenium (186Re) obisbemeda, according to a press release.

Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions 

These models are useful in predicting whether an unknown substance of abuse can permeate the BBB to produce effects predicted by the Public Health Assessment via Structural Evaluation (PHASE) approach.

New QSAR Model for Predicting Blood Brain Barrier Permeability

The recent revision is intended to provide guidance on QRM principles and tools that can be used for different aspects of pharmaceutical quality. 

ICH Q9(R1) Quality Risk Management Guidance Document Available

Presspart will still be responsible for the manufacturing of the Sunriser device.

Hovione and H&T Presspart Extend Partnership for Dry Powder Inhalation Formulation Delivery 

mRNA therapeutics are being researched to support the fight against rare diseases, infectious viruses, and cancers.

News